phasestudyotc

70 results found.

Top Stocks matching your search for "phase study otc"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 16, 2023

$RSLS Nice consolidation phase before this one goes.

Feb, 8, 2023

$RSLS nice green boom boom after closed offering ... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
BBAI

BigBear.ai Holdings Inc

-61.99%

$4.92 - $1.87

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 9, 2023

At 🌋 phase.

Feb, 3, 2023

$BBAI They have to factor in the jobs report which... See more

Image with triangles

Divihomes is Now Live

A new search platform that matches you with the best home improvement service providers in your area.

Instant Search & Match with Top Contractors

Instant Communication with Local Contractors

Phone Image with DiviHomes website

Millions of Unbiased User Reviews

100% Free Quotes from Top-Notch Contractors

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 20, 2023

It reported positive outcomes in pleural mesotheli... See more

Mar, 20, 2023

PROC data are excellent compared to any combo trials.

RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 16, 2023

$RSLS Nice consolidation phase before this one goes.

Feb, 8, 2023

$RSLS nice green boom boom after closed offering $FWBI new clinical study news $KPRX $CELZ $ICU

Jan, 3, 2023

$PBLA multiple phase 3 trail ..price 8 cents ..dirt cheap $KALA $RSLS $ATNF $PTPI

BBAI

BigBear.ai Holdings Inc

-61.99%

$4.92 - $1.87

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 9, 2023

At 🌋 phase.

Feb, 3, 2023

$BBAI They have to factor in the jobs report which was excellent as well, it means that AI isn't going to phase out a key aspect of the economy.

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 20, 2023

It reported positive outcomes in pleural mesothelioma patients, including: Improved survival: Study patients lived around 11 months.

Mar, 20, 2023

PROC data are excellent compared to any combo trials.

Mar, 8, 2023

But yesterdays paper also has me considering, if there isn't a deal with $mrk or $BMY or some other CPI BP --- That data is Best In Class - best in clinic, best in trial too.

Mar, 3, 2023

phase II results within weeks!!!

Feb, 27, 2023

Now phase 3 trial is showing similar results to date where patients are living longer after Galinpepimut-S up to 1.5 year longer is a breakthrough for AML patients.

Feb, 6, 2023

Positive trial data/results supported with bullish news and sentiment! 4.

Jan, 24, 2023

The nation’s best means the O'Neal Comprehensive Center in Alabama have access to the latest therapies, cutting-edge clinical trials and the expertise needed to treat their cancer.

Jan, 24, 2023

Gps is doing what it has done in every single trial and its the reason Patients are living 3 fold longer than patients on best available treatments.

Jan, 11, 2023

Treatment with GFH009 resulted in 90 to 100 percent cancer inhibition at dose levels equivalent to those already demonstrated to be safe in patients in the ongoing Phase 1 trial with no viable cancer cells at the highest dose levels.